(Q69806609)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3841382%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

title

The effects of nafazatrom in an acute occlusion-reperfusion model of canine myocardial injury (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3841382%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

author name string

V B Fiedler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3841382%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

M Mardin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3841382%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

E Perzborn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3841382%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

R Grützmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3841382%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

publication date

1 November 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3841382%20AND%20SRC:MED&resulttype=core&format=json

Naunyn-Schmiedeberg's Archives of Pharmacology

5 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3841382%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

volume

331

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3841382%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3841382%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

page(s)

267-274

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3841382%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00634248

5 October 2019

exact match

0 references

cites work

The beneficial effects of oral ibuprofen on coronary artery thrombosis and myocardial ischemia in the conscious dog

1 reference

12 December 2020

Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761)

1 reference

12 December 2020

The effects of oral nafazatrom (= BAY g 6575) on canine coronary artery thrombosis and myocardial ischemia

1 reference

12 December 2020

Electrical induction of coronary artery thrombosis in the ambulatory canine: a model for in vivo evaluation of anti-thrombotic agents

1 reference

12 December 2020

The antithrombotic activity of BAY g 6575

1 reference

12 December 2020

Antiaggregatory efficacy and its time-course after application of acetylsalicylic acid, prostacyclin and nafazatrom in vivo

1 reference

12 December 2020

Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation

1 reference

12 December 2020

Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog.

1 reference

12 December 2020

Coronary and systemic 6-ketoprostaglandin F1 alpha and thromboxane B2 during myocardial ischemia in dog

1 reference

12 December 2020

Neutrophil-aggregating activity of monohydroxyeicosatetraenoic acids

1 reference

12 December 2020

Stimulation of prostacyclin release from vessel wall by Bay g 6575, an antithrombotic compound

1 reference

12 December 2020

Macroscopic enzyme-mapping verification of large, homogeneous, experimental myocardial infarcts of predictable size and location in dogs

1 reference

12 December 2020

Elimination of prostacyclin (PGI2) and 6-oxo-PGF1α in anaesthetized dogs

1 reference

12 December 2020

The beneficial effects of nafazatrom (BAYg6575) on experimental coronary thrombosis.

1 reference

12 December 2020

Effects of dazoxiben on arrhythmias and ventricular fibrillation induced by coronary artery occlusion and reperfusion in anaesthetised greyhounds

1 reference

12 December 2020

Study of platelet aggregation in vivo. IX. Effect of nafazatrom on in vivo platelet aggregation and spontaneous tumor metastasis.

1 reference

12 December 2020

Prostacyclin in experimental myocardial ischemia: effects on hemodynamics, regional myocardial blood flow, infarct size and mortality

1 reference

12 December 2020

The effects of nafazatrom on arrhythmias and prostanoid release during coronary artery occlusion and reperfusion in anaesthetized greyhounds.

1 reference

12 December 2020

Reduction of myocardial infarction and dysrhythmic activity by nafazatrom in the conscious rat.

1 reference

12 December 2020

Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease

1 reference

12 December 2020

Nafazatrom-induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil function

1 reference

12 December 2020

Technique for precise, graded arterial stenosis and occlusion

1 reference

12 December 2020

Inhibition of platelet aggregation by acetylsalicylic acid and other inhibitors

1 reference

12 December 2020

Nafazatrom (BAY g 6575), a potent stimulator of prostacyclin release from cardiac and renal vessel wall

1 reference

12 December 2020

Salvage of ischemic myocardium by prostacyclin during experimental myocardial infarction

1 reference

12 December 2020

Outflow from the left and the right coronary artery into the coronary sinus in the dog heartin situ

1 reference

12 December 2020

Modulation of inflammatory reactions by prostaglandins

1 reference

12 December 2020

Beneficial effects of nafazatrom on ischemic reperfused myocardium

1 reference

12 December 2020

Nafazatrom (Bay g 6575) inhibition of tumor cell lipoxygenase activity and cellular proliferation

1 reference

12 December 2020

Nafazatrom (Bay g-6575), an antithrombotic and antimetastatic agent, inhibits 15-hydroxyprostaglandin dehydrogenase

1 reference

12 December 2020

Reduction of Acute Myocardial Ischemia in Rabbit Hearts by Nafazatrom

1 reference

12 December 2020

Effect of PGE1, PGE2 and PGI2 on ventricular arrhythmias during myocardial infarction in conscious dogs: relation to infarct size

1 reference

12 December 2020